Cowealth Medical China Co.Ltd. (603122) - Total Liabilities

Latest as of March 2026: CN¥367.76 Million CNY ≈ $53.81 Million USD

Based on the latest financial reports, Cowealth Medical China Co.Ltd. (603122) has total liabilities worth CN¥367.76 Million CNY (≈ $53.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Cowealth Medical China Co.Ltd. to track the company's year-over-year net asset growth rate.

Cowealth Medical China Co.Ltd. - Total Liabilities Trend (2019–2025)

This chart illustrates how Cowealth Medical China Co.Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See Cowealth Medical China Co.Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Cowealth Medical China Co.Ltd. Competitors by Total Liabilities

The table below lists competitors of Cowealth Medical China Co.Ltd. ranked by their total liabilities.

Company Country Total Liabilities
Guangzhou KingTeller Technology Co Ltd
SHE:002177
China CN¥25.84 Million
Taiwan Sakura Corp
TW:9911
Taiwan NT$4.04 Billion
Amotiv Limited
TO:AOV
Canada CA$279.03 Million
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
China CN¥1.42 Billion
PMET Resources Inc.
TO:PMET
Canada CA$37.43 Million
Fujian SuperTech Advanced Material Co Ltd
SHG:688398
China CN¥945.69 Million
Zhengping Road&Bridge Constr
SHG:603843
China CN¥6.93 Billion
Fitipower Integrated Technology Inc
TW:4961
Taiwan NT$3.76 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Cowealth Medical China Co.Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cowealth Medical China Co.Ltd. market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cowealth Medical China Co.Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cowealth Medical China Co.Ltd. (2019–2025)

The table below shows the annual total liabilities of Cowealth Medical China Co.Ltd. from 2019 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥368.90 Million
≈ $53.98 Million
+15.48%
2024-12-31 CN¥319.44 Million
≈ $46.74 Million
+9.21%
2023-12-31 CN¥292.49 Million
≈ $42.80 Million
-23.13%
2022-12-31 CN¥380.49 Million
≈ $55.68 Million
+17.15%
2021-12-31 CN¥324.78 Million
≈ $47.53 Million
-17.76%
2020-12-31 CN¥394.94 Million
≈ $57.79 Million
+15.93%
2019-12-31 CN¥340.68 Million
≈ $49.85 Million
--

About Cowealth Medical China Co.Ltd.

SHG:603122 China Diagnostics & Research
Market Cap
$576.65 Million
CN¥3.94 Billion CNY
Market Cap Rank
#11287 Global
#3048 in China
Share Price
CN¥9.90
Change (1 day)
-3.98%
52-Week Range
CN¥6.28 - CN¥30.01
All Time High
CN¥30.01
About

Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company w… Read more